Joseph L. Jilek
- Cancer Research top 10%
- MicroRNA in disease regulation 7
-
- RNA Interference and Gene Delivery 6
- Epigenetics and DNA Methylation 4
- Genomics, phytochemicals, and oxidative stress 2
-
- Drug Transport and Resistance Mechanisms 4
-
- Liver Disease Diagnosis and Treatment 5
-
- Birth, Development, and Health 4
- Pharmacological Effects and Toxicity Studies 3
- Journals
- Drug Metabolism and Disposition (8 papers)Toxicological Sciences (2 papers)Acta Pharmaceutica Sinica B (2 papers)
- Partner nations
- United StatesChina
In The Last Decade
Joseph L. Jilek
24 papers receiving 538 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 179
- Molecular Biology 357
- Pharmacology 30
- Oncology 81
- Physiology 12
Countries citing papers authored by Joseph L. Jilek
This map shows the geographic impact of Joseph L. Jilek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Jilek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Jilek more than expected).
Fields of papers citing papers by Joseph L. Jilek
This network shows the impact of papers produced by Joseph L. Jilek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Jilek. The network helps show where Joseph L. Jilek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph L. Jilek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 19 | |
| 11 | 2019 | 50 | |
| 12 | 2018 | 52 | |
| 13 | 2018 | 41 | |
| 14 | 2017 | 53 | |
| 15 | 2016 | 26 | |
| 16 | 2015 | 56 | |
| 17 | 2015 | 17 | |
| 18 | 2015 | 64 | |
| 19 | 2015 | 9 | |
| 20 | 2015 | 13 |
About Joseph L. Jilek
Joseph L. Jilek is a scholar working on Cancer Research, Hepatology and Transplantation, having authored 25 papers that have together received 541 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), RNA Interference and Gene Delivery (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Birth, Development, and Health (4 papers), Epigenetics and DNA Methylation (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Cancer Research (179 citations), Molecular Biology (357 citations) and Pharmacology (30 citations). Joseph L. Jilek has collaborated with scholars based in United States and China. Frequent co-authors include Ai‐Ming Yu, Mei‐Juan Tu, Pui Yan Ho, Zhijian Duan, Ye Tian, Karilyn E. Sant, Craig Harris, Qiuxia Chen, Dana C. Dolinoy and Jingxin Qiu. Their work appears in journals such as Drug Metabolism and Disposition, Toxicological Sciences, Acta Pharmaceutica Sinica B, Journal of Pharmacology and Experimental Therapeutics and The Journal of Nutritional Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.